当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析

科伦药业

(002422)

  

流通市值:500.23亿  总市值:612.77亿
流通股本:12.99亿   总股本:15.91亿

科伦药业(002422)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润4.73亿元,每股收益0.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益2974684.55万元,未分配利润1263375.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产4114181.02万元,负债1139496.47万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入4,259,244,93618,512,918,90713,276,729,7639,083,327,620
营业总成本3,990,126,05216,435,765,00311,864,487,3737,818,465,981
其他经营收益
营业利润356,491,4772,521,049,6661,779,909,0671,513,437,194
利润总额441,048,2092,403,835,5881,648,930,0821,417,649,449
净利润472,700,2741,877,211,2081,244,770,5181,113,856,403
每股收益
其他综合收益-57,105,201-51,730,405-43,268,342-39,588,443
综合收益总额415,595,0731,825,480,8031,201,502,1761,074,267,960
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计21,284,915,87720,040,018,94920,505,152,41719,583,664,737
非流动资产:
非流动资产合计19,856,894,33319,794,804,37619,599,146,01119,466,837,700
资产总计41,141,810,21039,834,823,32540,104,298,42839,050,502,437
流动负债:
流动负债合计10,066,130,0949,189,628,60810,157,762,7449,075,838,590
非流动负债:
非流动负债合计1,328,834,5981,351,301,0541,323,667,6591,309,657,831
负债合计11,394,964,69210,540,929,66211,481,430,40310,385,496,421
所有者权益(或股东权益):
归属于母公司股东权益合计24,638,160,53024,224,470,76023,707,836,19523,679,226,041
股东权益合计29,746,845,51829,293,893,66328,622,868,02528,665,006,016
负债和股东权益合计41,141,810,21039,834,823,32540,104,298,42839,050,502,437
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计5,010,027,57522,380,191,67016,046,074,51610,728,655,782
经营活动现金流出小计4,760,416,25819,738,123,38514,361,632,1849,539,120,905
经营活动产生的现金流量净额249,611,3172,642,068,2851,684,442,3321,189,534,877
投资活动产生的现金流量:
投资活动现金流入小计7,754,878,98224,445,800,11320,383,103,84812,803,165,508
投资活动现金流出小计8,549,234,08125,734,061,08521,766,266,51013,331,669,627
投资活动产生的现金流量净额-794,355,099-1,288,260,972-1,383,162,662-528,504,119
筹资活动产生的现金流量:
筹资活动现金流入小计2,604,972,3316,802,544,4696,181,756,8593,819,952,541
筹资活动现金流出小计1,558,662,8936,118,515,1884,104,803,5522,651,968,429
筹资活动产生的现金流量净额1,046,309,438684,029,2812,076,953,3071,167,984,112
汇率变动对现金及现金等价物的影响-806,895-45,926,939-8,625,875-2,186,965
现金及现金等价物净增加额500,758,7611,991,909,6552,369,607,1021,826,827,905
期末现金及现金等价物余额6,437,430,4905,936,671,7296,314,369,1765,771,589,979
补充资料:
现金及现金等价物的净增加额-1,991,909,655-1,826,827,905
最新报告期:2026-05-07
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
野村东方国际证券孔令岩1.231.551.922026-05-07
华泰证券代雯,孙茗馨,沈卢庆1.291.672.042026-04-29
东海证券付婷,杜永宏1.281.471.752026-04-15
西部证券李梦园1.361.571.852026-04-13
中信建投袁清慧,贺菊颖,魏佳奥1.281.501.772026-04-10
TOP↑